BioSpace News Archive

Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the publication of two manuscripts in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research (AACR).

Olympus announced today FDA 510(k) clearance of Narrow Band Imaging ® (NBI) to assess the neoplastic potential of colorectal polyps.

The Centre for Disease Control and Prevention has declared insufficient sleep a ‘public health problem’, with more than one-third of American adults not getting enough sleep on a regular basis.

Roche – the leader in personalized medicine and the world’s greatest biotechnological company – provides end-to-end integral and strategic solutions to the Roche Pharmaceutical and Diagnostic divisions all over the Americas in areas such as finance, People & Culture, purchasing, and information technologies.

Resverlogix Corp. (“Resverlogix”) (TSX:RVX) announced today the publishing of a new article titled: “Bromodomain and extraterminal protein inhibitor, apabetalone (RVX-208), reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro”, on the pre-print server, bioRxiv.

Gamida Cell Presents Efficacy and Safety Results of Phase 3 Study of Omidubicel in Patients with Hematologic Malignancies at the 47 th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) -Abstract will be shared at Presidential Symposium and featured in this year’s “Live with Best Abstracts” session-

SpectronRx, a leading radiopharmaceutical contract development and manufacturing organization (CDMO), announced today that the U.S. Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters.

Both 5-MeO-DMT and DMT possess unique pharmacodynamic and pharmacokinetic properties compared to other clinically studied psychedelics, including a shorter duration of action, which may help reduce the amount of time a patient would spend in the clinic during psychedelic-assisted psychotherapy.

ExonanoRNA LLC., based in Columbus, Ohio, and MDimune Inc., headquartered in Seoul, South Korea, have entered into a service agreement to develop targeted siRNA therapy in oncology application on March 8th, 2021.

The American Academy of Orthopaedic Surgeons announced Georgia orthopaedic surgeon Daniel K. Guy, MD, FAAOS, as its new president.